Electronic Public Notices
In accordance with Article 440 of the Companies Act, the electronic public notice system is adopted. However, if electronic public notice is not possible due to accidents or other unavoidable reasons, it will be published in the official gazette, etc.
August 19, 2024
June 30, 2024
February 28, 2024
June 5, 2023
May 20, 2019
May 10, 2018
Corporate Information Overview
KIYAN PHARMA Co., Ltd. advances the development of new drugs using the natural amino acid 5-ALA.
5-ALA through continuous innovation and delivering innovative healthcare products to bring health and a prosperous life.
Based on years of research and scientific knowledge of 5-ALA, contributing to global healthcare as a leading company handling 5-ALA.
Aiming for our products and services to become indispensable in daily life and to support the foundation of people’s health.
Manufacturing 5-ALA for various applications and expanding the production of pharmaceutical APIs and intermediates.
Providing the latest official information promptly. Posting important notices for all stakeholders.
Company Introduction Videos
KIYAN PHARMA Co., Ltd. is introduced through an easy-to-understand animated video.
Fukuroi Plant and the 5-ALA production process are provided through a variety of videos.
